Canaccord Genuity maintains a 'Speculative Buy' Æterna Zentaris (NASDAQ: AEZS), raising target to US$2.75 from US$2.60.

Canaccord analyst says, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE